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Introduction {#sec005}
============

At the end of December 2019, a cluster of cases of coronavirus disease-2019 (COVID-19) were first reported in Wuhan, China \[[@pone.0237420.ref001]\]. On 23 January 2020, the municipal government of Wuhan announced the lockdown of the entire city, and China implemented a national emergency mechanism with different cities adopting different measures according to their respective situations. On 30 January 2020, the WHO declared COVID-19 to be a "public health emergency of international concern", and the US recorded its first confirmed case of human-to-human transmission in Chicago \[[@pone.0237420.ref002], [@pone.0237420.ref003]\]. It is evident that the lockdown in Wuhan has played a critical role in limiting the scope of the COVID-19 epidemic in China.

Since then, the life-threatening COVID-19 outbreak has become a global pandemic. By 5 April 2020, the global number of confirmed cases had exceeded 1.1 million, with a daily increase of approximately 0.1 million cases. To cope with this disaster, an increasing number of government agencies in the US and European countries have implemented lockdown policies to prevent the rapid spread of COVID-19. During the lockdown, city residents are required to refrain from leaving home and to practice social distancing. In the past two months, scholars began to pay attention to the management of pregnancy and childbirth during the COVID-19 pandemic. Previous studies have shown that pregnancy while infected with severe acute respiratory syndrome coronavirus (SARS-CoV) was associated with adverse maternal and neonatal complications, such as spontaneous miscarriage, preterm delivery, intrauterine growth restriction, the need for endotracheal intubation, admission to the intensive care unit, renal failure, and disseminated intravascular coagulopathy \[[@pone.0237420.ref004], [@pone.0237420.ref005]\].

Although the possible risks associated with COVID-19 and the clinical characteristics of pregnant women with laboratory-confirmed COVID-19 have been investigated \[[@pone.0237420.ref006], [@pone.0237420.ref007]\], previous research has failed to address the impact of lockdown during the COVID-19 epidemic. Unlike other activities that can be carried out online or at home, delivery cannot be delayed arbitrarily or performed at home. The lockdown in Wuhan may have a significant impact on the outcome of pregnancy due to pathological factors, the timeliness of examinations, psychological panic, limited medical resources, difficulty accessing and transportation, etc. An essential question that is important for obstetricians to consider is how does the lockdown affect the indications for different modes of delivery and newborn health?

This study answers the question based on an analysis of the data from more than 10,000 cases from our working hospital in Wuhan, the Maternal and Child Hospital of Hubei Province, which has one of the largest obstetrics departments of all Chinese hospitals. The department delivered approximately 25,000 babies annually in the last five years. During the COVID-19 epidemic, our hospital was identified as a non-designated hospital with a fever clinic accept pregnant women who were not infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and those who were suspected of being infected. The latter patients who received laboratory-confirmation of infection via quantitative qPT-PCR for SARS-CoV-2 using a throat swab were transferred to designated hospitals for further treatment. During the lockdown in Wuhan, a total of 3,432 pregnant women underwent delivery in our birth center, and a few cases of COVID-19 were confirmed in pregnant women. In this study, we compared the indications for cesarean delivery (CD) and the birth weights of newborns born to 3,432 pregnant women who gave birth during lockdown and 7,159 propensity score-matched pregnant women who gave birth before the lockdown were selected as the control group.

Methods {#sec006}
=======

Study design and patients {#sec007}
-------------------------

[Fig 1](#pone.0237420.g001){ref-type="fig"} illustrates the subject selection process. Pregnant women who had given birth in the birth center of the Maternal and Child Health Hospital of Hubei Province from 23 January 2020 to 14 March 2020 were enrolled as the observation group. The age of the selected patients ranged from 18 to 50 years old. The exclusion criteria included a gestational age less than 28 weeks and intrauterine fetal death. A total of 3442 pregnant women were initially included, among whom 5 with gestational age less than 28 weeks of and 5 with intrauterine fetal death were excluded. The remaining 3432 patients constituted the observation group.

![Population flow chart of the retrospective study.](pone.0237420.g001){#pone.0237420.g001}

From 29, 799 historical patients from 1 January 2019 to 22 January 2020, the control group included a total of 7,159 patients based on the propensity score matching (PSM) method as. The PSM method, a quasi-experimental design that has been used across disciplines to isolate treatment effects on a number of outcomes using observational data, was employed in this study to obtain matched patients to facilitate comparisons \[[@pone.0237420.ref008]\]. Based on three variables of age, gravidity, and parity, 7159 pregnant women were selected as the control group from the 29799 patients before the lockdown using the PSM method. The balanced scores of the two groups were 0.10312 and 0.10590, which were very similar.

Data collection {#sec008}
---------------

In our department, one nurse is responsible for the daily recording of the delivery information of all the pregnant women into the Electronic Medical Record System (EMRS). In this research, obstetricians extracted the required data, including epidemiological, demographic, clinical, laboratory, and pregnancy outcome data for both the observation group and control group. The neonates' data including birth weight, clinical symptoms, Apgar score, and outcomes were also collected. During this period, all pregnant women with COVID-19 symptoms, such as fever, cough, and abnormal CT scan results, underwent nucleic acid detection of COVID-19 of SARS-COV02 from swab samples. In total, 13 pregnant women had confirmed COVID-19, including 8 pregnant women who underwent CD. Their throat swab samples were collected and sent to the local Chinese Center for Disease Control and Prevention (CDC), which was in charge of detecting SAS-COV-2 by qRT-PCR. The results for each woman suspected of having COVID-19 was entered into the EMRS.

Statistical methods {#sec009}
-------------------

Statistical analysis was performed using SPSS 22.0. The chi-square test was used for the comparison of countable data. The *t*-test and Fisher's exact probability method were used for the comparison of the means between the measurement data. The rank sum test was used for ranking variables. A difference was statistically significant at *p*\<0.05.

Results {#sec010}
=======

A comparison of the observation group and control group is shown in [Table 1](#pone.0237420.t001){ref-type="table"}. There were no significant differences in maternal age, gravidity, parity history, or BMI between the two groups (*p*\>0.05). At the same time, there were no differences in the proportions of preterm and term neonates between the two groups (*p*\>0.05).

10.1371/journal.pone.0237420.t001

###### Comparison of the general situation of pregnant women.

![](pone.0237420.t001){#pone.0237420.t001g}

                                        Before lockdown (n = 7159)   After lockdown (n = 3432)   Chi-square   *p*-value          
  ------------------------- ----------- ---------------------------- --------------------------- ------------ ----------- ------ ------
  Age                       \<35        6385                         89                          3095         90          2.43   0.12
  ≥35                       774         11                           337                         10                              
  Gravida                   1           3288                         46                          1544         45          1.44   0.70
  2                         2003        28                           981                         29                              
  3                         1113        16                           527                         15                              
  ≥4                        754         10                           380                         11                              
  Para                      Primipara   4685                         65                          2243         65          0.01   0.93
  Multiparas                2474        35                           1189                        35                              
  BMI                       \<25        6665                         93                          3167         92          2.35   0.16
  ≥25                       494         7                            265                         8                               
  Preterm and term births   Preterm     615                          9                           281          8           0.49   0.47
  Term                      6544        91                           3151                        92                              

[Table 2](#pone.0237420.t002){ref-type="table"} shows the comparison of the rates of CD and vaginal delivery before and after lockdown. The data show that there was no significant difference between the two groups (*p*\>0.05). In fact, the CD rate in the observation and control groups were 47.49% and 47.70%, respectively.

10.1371/journal.pone.0237420.t002

###### CD rate and vaginal delivery rate before and after lockdown.

![](pone.0237420.t002){#pone.0237420.t002g}

                      Before lockdown (n = 7159)   After lockdown (n = 3432)   Chi-square   *p-*value          
  ------------------- ---------------------------- --------------------------- ------------ ----------- ------ ------
  Vaginal delivery    3759                         53                          1795         52          0.04   0.84
  Cesarean delivery   3400                         47                          1637         48                 

[Table 3](#pone.0237420.t003){ref-type="table"} shows the comparison of the indications for CD. There were no significant differences in most of the pregnancy complications between the observation group and control group. The number of pregnant women who underwent CD due to fetal distress in the observation group was significantly higher than that in the control group (*p\<0*.*05*). In addition, the incidence of CDMR in the observation group was significantly higher than that in the control group (*p*\<0.05). CDMR was defined as a primary prelabor cesarean delivery performed on maternal request in the absence of any maternal or fetal indications \[[@pone.0237420.ref009]\]. In the observation group, 13 cases of COVID-19 were confirmed by chest CT scan and two positive laboratory tests for SARS-CoV-2 in throat swab samples. Eight of those 13 patients with confirmed COVID-19 underwent CD. There were 0 COVID-19 cases in the control group. The other indications for CD in the observation group were not significantly different than those in the control group.

10.1371/journal.pone.0237420.t003

###### Comparison of the indications of CD.

![](pone.0237420.t003){#pone.0237420.t003g}

                                                 Before lockdown (n = 3400)   After lockdown (n = 1637)   Chi-square   *p*-value           
  ---------------------------------------------- ---------------------------- --------------------------- ------------ ----------- ------- ---------------------------------------------------
  Scar uterus                                    1128                         33                          553          34          0.18    0.67
  Fetal distress                                 537                          15                          297          18          4.41    **\<0.05**
  Abnormal fetal position                        338                          10                          137          8           3.20    0.07
  Cesarean delivery on maternal request (CDMR)   284                          8                           186          11          11.83   **\<0.05**
  Giant fetus                                    210                          6                           83           5           2.47    0.12
  Hypertension                                   205                          6                           79           5           3.01    0.08
  Multiple pregnancy                             133                          4                           68           4           0.17    0.68
  Placenta previa                                94                           3                           32           2           2.97    0.09
  Induction of labor failure                     74                           2                           30           2           0.65    0.42
  Prenatal fever                                 69                           2                           26           2           1.16    0.28
  Labor abnormalities                            46                           1                           22           1           0.02    0.98
  ICP[^b^](#t003fn002){ref-type="table-fn"}      37                           1                           17           1           0.03    0.87
  Placental abruption                            33                           1                           13           1           0.38    0.54
  Diabetes                                       31                           1                           12           1           0.42    0.52
  Umbilical cord                                 22                           1                           5            0           2.42    0.12
  Genital malformation                           14                           0                           13           1           3.03    0.08
  FGR[^c^](#t003fn003){ref-type="table-fn"}      11                           0                           1            0           3.20    0.07
  COVID-19                                       0                            0                           8            0                   **\<0.05**△[^a^](#t003fn001){ref-type="table-fn"}
  Others                                         34                           1                           17           1           0.02    0.90

^a^△means Fisher\'s exact probability method, because the frequency of cells appears 0

^b^ICP means intrahepatic cholestasis of pregnancy

^c^FGR means fetal growth restriction

Neonatal asphyxia is divided into mild asphyxia and severe asphyxia, which are mainly evaluated based on the Apgar score. According to the Apgar score, a total score from 0 to 3 is classified as severe asphyxia, from 4 to 7 is classified as mildly asphyxiated, and from 8 to 10 is normal \[[@pone.0237420.ref010]\]. [Table 4](#pone.0237420.t004){ref-type="table"} shows that there was no significant difference in neonatal asphyxia between the two groups (*p\>0*.*05*).

10.1371/journal.pone.0237420.t004

###### Comparison result on neonatal asphyxia.

![](pone.0237420.t004){#pone.0237420.t004g}

                    Neonatal asphyxia   *z-*value   *p*-value                       
  ----------------- ------------------- ----------- ----------- --- ---- --- ------ ------
  Before lockdown   7097                99          51          1   11   0   0.54   0.46
  After lockdown    3407                99          19          1   6    0          

As shown in [Table 5](#pone.0237420.t005){ref-type="table"}, the neonatal birth weight in the observation group was heavier than that in the control group among those with ≥34 gestational weeks (*p*\<0.05). However, there was no significant difference among those with fewer than 34 gestational weeks (*p\>0*.*05*).

10.1371/journal.pone.0237420.t005

###### Newborn weight at different gestational age.

![](pone.0237420.t005){#pone.0237420.t005g}

  Newborn group                     Before lockdown (g)   After lockdown (g)   *t*-value   *p-*value
  --------------------------------- --------------------- -------------------- ----------- ------------
  28 ≤ gestational age(wks) \<32    1,462±318             1479±231             -0.26       0.80
  32 ≤ gestational age(wks) \< 34   1,926±313             2,021±253            -1.54       0.13
  34 ≤ gestational age(wks) \< 37   2,583±424             2,652±3856           -2.06       **\<0.05**
  37 ≤ gestational age(wks) \< 38   3,167±385             3,207±398            -2.95       **\<0.05**
  gestational age(wks) ≥39          3,402±370             3,426±384            -2.32       **\<0.05**

Discussion {#sec011}
==========

This paper presents a comparison of the indications for CD and newborn weights before and after the Wuhan lockdown. All the patients in the observation group and the control group were collected from the Maternal and Child Health Hospital of Hubei Province. During the lockdown to prevent the spread of the COVID-19 outbreak from 23 January 2020 to 13 March 2020, a total of 49,995 cases were confirmed in Wuhan with 2,446 deaths \[[@pone.0237420.ref011]\].

In our empirical study, the overall CD rate was not significant different between the observation group and the control group. The differences in most of the indications for CD between the observation group and control group were not significant. This may serve as reassurance to many pregnant women who are currently having to remain primarily at home that a lockdown is unlikely to dramatically affect complications of pregnancy. However, we empirically observed that the rate of CDMR increased significantly during this period. CDMR may reduce the risk of hemorrhage and transfusion, but is also potentially associated with a longer maternal hospital stay, an increased risk of respiratory problems for the infant, and the need for hysterectomy \[[@pone.0237420.ref009]\]. The main reason for the increase in the rate of CDMR was that the pregnant women in Wuhan were reluctant to wait for a natural birth due to fear of COVID-19 infection during hospitalization. After the city was locked down, 8 out of 13 pregnant women with confirmed COVID-19 underwent CD in our birth center. Severe COVID-19 was treated as an indication for CD according to the Chinese Expert Consensus \[[@pone.0237420.ref012]\]. If a pregnant woman had mild or asymptomatic COVID-19 and her cervix was dilated, vaginal delivery could be selected. If the fetus was in distress, the level of control of COVID-19 was unsatisfactory, or there were other indications for CD, CD was performed by obstetricians \[[@pone.0237420.ref013]\].

During the Wuhan lockdown, pregnant women had to remain in their homes, limiting their ability to exercise and attend appointments. They reduced the frequency of prenatal examinations because they were afraid of contracting COVID-19, and some pregnant women were never examined from the initiation of lockdown until delivery. Therefore, some important risk factors may not have been detected in a timely manner, leading to an increased incidence of fetal distress.

Through the comparison of the observation group and the control group, we found that lockdown may have led to heavier newborns with a gestational age greater than 34 weeks. The possible underlying contributory factors might include food and nutrition changes and lack of exercise. During pregnancy, balanced nutrition and adequate intake of vegetables and protein have a positive impact on the birth weight of the neonate \[[@pone.0237420.ref014]--[@pone.0237420.ref016]\]. However, due to the COVID-19 in Wuhan, supermarkets and vegetable markets were closed, and access to nutrient-rich food was relatively restricted. The relative lack of vegetables and food high in crude fiber, and the increased intake of carbohydrate-rich foods, such as rice and noodles, which were easily obtained and stored, led to an increase in neonatal weight. In addition, after the city was locked down, pregnant women became less active and exercised less. We recommend that during a city lockdown due to COVID-19, pregnant women should try to eat a balanced diet, increasing their intake of protein and vegetables as much as possible and controlling their intake of carbohydrates such as rice noodles, and increase their engagement in indoor activities.

Our research has some limitations. First, due to the reduction in or even absence of examinations of pregnant women, we could not collect the data on changes in body weight during this period. Second, the findings might have been affected by other factors, such as climate, food type, and other uncontrollable inputs, because the observation group was collected from a short period in 2020. The research question investigated in this study needs further exploration with other data sets.

Supporting information {#sec012}
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Within one week, you'll receive an e-mail detailing the required amendments. When these have been addressed, you'll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at <http://www.editorialmanager.com/pone/>, click the \'Update My Information\' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at <authorbilling@plos.org>.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they'll be preparing press materials, please inform our press team as soon as possible \-- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact <onepress@plos.org>.

Kind regards,

Cheryl S. Rosenfeld, DVM, PhD

Section Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers\' comments:

Reviewer\'s Responses to Questions

**Comments to the Author**

1\. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the "Comments to the Author" section, enter your conflict of interest statement in the "Confidential to Editor" section, and submit your \"Accept\" recommendation.

Reviewer \#1: All comments have been addressed

\*\*\*\*\*\*\*\*\*\*

2\. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer \#1: (No Response)

\*\*\*\*\*\*\*\*\*\*

3\. Has the statistical analysis been performed appropriately and rigorously?

Reviewer \#1: (No Response)

\*\*\*\*\*\*\*\*\*\*

4\. Have the authors made all data underlying the findings in their manuscript fully available?

The [PLOS Data policy](http://www.plosone.org/static/policies.action#sharing) requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data---e.g. participant privacy or use of data from a third party---those must be specified.

Reviewer \#1: (No Response)

\*\*\*\*\*\*\*\*\*\*

5\. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer \#1: (No Response)

\*\*\*\*\*\*\*\*\*\*

6\. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer \#1: The paper is now suitable for publication. The written English is much improved and the the conclusions suitably muted.

\*\*\*\*\*\*\*\*\*\*

7\. PLOS authors have the option to publish the peer review history of their article ([what does this mean?](https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history)). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

**Do you want your identity to be public for this peer review?** For information about this choice, including consent withdrawal, please see our [Privacy Policy](https://www.plos.org/privacy-policy).

Reviewer \#1: No
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Dear Dr. Zhao:

I\'m pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they\'ll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact <onepress@plos.org>.

If we can help with anything else, please email us at <plosone@plos.org>.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Cheryl S. Rosenfeld

Section Editor

PLOS ONE
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